![]() |
||||||||
Select Publications
Coleman E et al. Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations. Cancer Treat Rev 2008;34(3):275-82. Abstract
Crew KD et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007;25(25):3877-83. Abstract
Cuzick J et al. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial. Lancet Oncol 2008;9(12):1143-8. Abstract
Ingle JN et al. Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: Meta-analyses of randomized trials of monotherapy and switching strategies. Presentation. San Antonio Breast Cancer Symposium 2008;Abstract 12.
Morales L et al. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 2008;26(19):3147-52. Abstract
Mouridsen HT et al. BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Presentation. San Antonio Breast Cancer Symposium 2008;Abstract 13.
EDITOR
Neil Love, MD
Harold J Burstein, MD, PhD
- Select publications
Jack Cuzick, PhD
- Select publications
Howard A Burris III, MD
- Select publications
Mark D Pegram, MD
- Select publications
Breast Cancer Update:
A CME Audio Series and Activity